Futility and Potentially Inappropriate Treatment in Massive Transfusion - ABC Bulletin October 2024

On behalf of Carter Bloodcare and ABC’s Scientific, Medical, and Technical (SMT) Publications Committee, please find the October 2024 Issue of the Blood Bulletin, titled “Futility and Potentially Inappropriate Treatment in Massive Transfusion.”

The issue was written by Richard Gammon, MD, Chief Medical Officer at Carter BloodCare; Daniela Hermelin, MD, Chief Medical Officer at ImpactLife; Kirsten Alcorn, MD, Co-Chief Medical Officer at Bloodworks Northwest; Kip Kuttner, DO, Vice President and Medical Director at Miller-Keystone Blood Center; Louis Katz, MD, Chief Medical Officer Emeritus at ImpactLife; Nanci Fredrich, RN, BSN, MM, Transfusion Safety Officer, Versiti Blood Center of Wisconsin; Courtney Hopkins, DO, Senior Medical Officer at Vitalant; Timothy Pancioli, DO, Associate Medical Director at Versiti, Kevin Ha, MD, Associate Medical Director at Versiti; and Theresa Nester, MD, Co-Chief Medical Officer at Bloodworks Northwest.

We extend our tremendous gratitude to the following contributors for their expert guidance and insightful contributions to this Blood Bulletin: Jed Gorlin, MD, MBA, Chief Medical Officer of Americas Blood Centers; Walter Dzik, MD, Associate Professor of Pathology, Harvard Medical School; Steven M Frank, MD, Professor, Anesthesiology/Critical Care Medicine, Johns Hopkins Medical Institutions; Diane Calmus, JD, Vice President of Government Affairs of America’s Blood Centers; Joel Wu, JD, MPH, MA, HEC, Clinical Ethics Assistant Professor, Center for Bioethics, University of Minnesota; and Debra DeBruin, PhD, Director, Center for Bioethics, University of Minnesota.

Blood Bulletin is reviewed and edited by ABC’s SMT Publications Committee.

If there are topics that would be useful to you in your educational program or in addressing frequently asked questions, please contact ABC. They will gladly consider these suggestions for a future issue.